VirTra Wins Five-Year CBP Contract With Up to $14 Million in Potential Value

VirTra, Inc. (VTSI) secured a five-year, $14 million contract with U.S. Customs and Border Protection (CBP) to maintain and modernize its training systems. The contract, starting Q1 2027, includes hardware and software upgrades, support, and maintenance. VirTra's CEO highlighted the opportunity to extend customer relationships and support CBP's training operations across the U.S. and territories.

Original reporting
Published Oct 6, 2026, 8:00 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 6, 2026, 8:01 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$VTSI
Bullish
high confidence
Mentioned
$VTSI
Relevance
6/10
AlphAI data visualization · based on globenewswire.com
Decision brief

The 30-second read

$VTSIBullishMed
01

Why it matters

The award underscores VirTra's position as a preferred supplier for federal training, potentially opening doors to other agencies.

02

Market read

A new federal contract could lift VirTra's stock modestly, while highlighting the niche market for training simulators.

03

What to watch

Potential competition for future renewals and the reliance on a single government customer.

Relevance 6/10Novelty 6/10Timing: today

Background

VirTra provides simulation‑based training for law enforcement and military agencies; the CBP contract extends its existing installed base.

Company-level read

Ticker impact

$VTSIBullishHigh confidence
Context

VirTra announced a new five‑year sole‑source contract with U.S. Customs and Border Protection worth up to $14 million.

Expected impact

likely modest upside as investors price in the new federal contract

Evidence & confidence

First‑time disclosure of a multi‑year government contract; market typically reacts positively to secured federal revenue.

Market effects

May boost sentiment for defense and public‑sector technology providers.

U.S. federal contractors could see modest buying interest.

Limited to U.S. markets; no direct global ripple.

Counterpoint

The contract size is modest and not guaranteed; investors may wait for actual order flow before pricing in.

Key entities

  • VirTra, Inc.

    Provider of immersive training simulators.

  • U.S. Customs and Border Protection

    Federal agency awarding the contract.

Related articles

$VTSIMed

VirTra Reports Third Quarter and Nine Months 2026 Financial Results

VirTra, Inc (VTSI) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 VirTra Reports Third Quarter and Nine Months 2026 Financial Results CHANDLER, Ariz. — November 12, 2026 — VirTra, Inc . (Nasdaq: VTSI) ( “ VirTra ” or the “ Company ” ), a global provider of judgmental use-of-force and firearms training simulators, reported results f

$VTSIMed

VirTra Reports Second Quarter and Six Months 2026 Financial Results

VirTra, Inc (VTSI) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 VirTra Reports Second Quarter and Six Months 2026 Financial Results CHANDLER, Ariz. — August 13, 2026 — VirTra, Inc . (Nasdaq: VTSI) ( “ VirTra ” or the “ Company ” ), a global provider of judgmental use-of-force and firearms training simulators, reported results for

$VTSIMedAI 8/10

VirTra (NASDAQ:VTSI) Trading Down 2.9% – What’s Next?

VirTra (NASDAQ:VTSI) shares fell 2.9% to $3.33 on Monday, after trading as low as $3.22; the session volume of 107,453 shares was up 45% versus the average. Research firms cited mixed views: Lake Street cut its target to $5.00 (buy), while Wall Street Zen and Zacks cut to sell/strong sell. In its May 11 quarter, VirTra reported EPS of -$0.12 and revenue of $3.47M.

$SLSMedAI 8/10

SLS Stock Surges After-Hours: Sellas Says 'Transformative' Phase 3 AML Results Are Coming This Month

Sellas (SLS) stock rose after-hours following news of upcoming Phase 3 AML trial results. The Phase 2 study showed 34% response rate, with higher efficacy in specific subtypes. Sellas has $134.7M in cash, with Q3 net loss widening to $10.1M. The company plans to study SLS009 in pancreatic cancer. Retail sentiment improved to 'neutral'. SLS stock is up 113% year-to-date.

$FWDIMed

Forward Industries to Take Up to $30M Stake in GromaCoin Ahead of Solana Launch

Forward Industries (FWDI) plans to invest up to $30M in GromaCoin (GRO), a tokenized real estate asset on the Solana blockchain, launching in Q1 2027. GromaCoin represents shares in Groma Real Estate Trust, currently for accredited investors. The investment expands Forward's exposure to tokenized assets. Groma aims for a $75M investment capacity in its first year and plans to integrate with Solana-based lending protocol Kamino.